Google+ Facebook Twitter Twitter

Tech news: December 2022

This month's top tech news stories

Maine Standards

Documentation Platforms

Maine Standards has released VALIDATE CM2 kits for the Polymedco PATHFAST platforms for easy, fast, and reliable documentation of linearity and calibration verification.

VALIDATE CM2 test kits are frozen liquid and ready-to-use; simply dispense the solution from each dropper bottle directly into five sample cups and run in replicates to verify the assay’s reportable range.

LGC Clinical Diagnostics

Omicron antigens

The Native Antigen Company, part of LGC Clinical Diagnostics, has announced the commercial launch of its latest SARS-CoV-2 antigens for the newly designated Omicron BA.5 variant. The company’s new range of receptor binding domain (RBD) antigens will support scientists in the research and development of in vitro diagnostics, therapeutics and vaccines for the current variant of concern,which now accounts for more than 50% of the world’s cases of COVID-19.

Muna Therapeutics

Parkinson’s disease

Muna Therapeutics, a biopharmaceutical company discovering and developing novel therapeutics for the Parkinson’s disease and other neurodegenerative disorders, has been awarded a $4.9 million grant from the Michael J. Fox Foundation for Parkinson’s Research. The grant will be used to support ongoing preclinical research and development of novel, brain-exposed, small molecule potassium channel type 1.3 (Kv1.3) blockers to abrogate neuroinflammation driven by disease-associated microglia and enhance neuroprotection.

Image credit | iStock | Shutterstock

Related Articles

Role of glucose in a deadly kidney disease

A research team has developed a new approach to better understand the biology of polycystic kidney disease (PKD).

Recent advances and updates in biomedical science

Deputy Editor Guy Orchard summarises a review paper and looks at planned special issues of the British Journal of Biomedical Science.

Replacing injections with pills?

A new paper explores a better way of delivering medications that does not require injections but could be as easy as swallowing a pill.

Trial to rapidly find flu treatments

A national trial has launched that aims to use pandemic lessons to help quickly find effective treatments for people hospitalised with severe flu.